MedPath

Effect of a new drug ( Methyl-Naltrexone) in reducing urinary complication after use of Morphine

Not Applicable
Conditions
rinary Retention.
Disorder of urinary system, unspecified
Registration Number
IRCT201204145172N3
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

18 – 50 years old patient ; planned orthopedic surgery on lower Extremities; usual criteria for spinal anesthesia

Exclusion Criteria : Peri-op Int. folley; Genito-urinary problems (Benign prostatic hyperplasia, Urinary stone, Renal failure, … ); Addiction (in 6 mounts before operation) ; Use of opioids in 12 hours before operation; Neurologic Disease (stroke, alcohol/diabete neuropathies, cerebral palsy, spinal lesions, multiple sclerosis, poly myositis ) ; Drugs ( anti-cholinergics, ß-blockers, Sympathomimetics, a-agonists/antagonists)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rinary retention. Timepoint: every 1 hour till 24 hours after surgery. Method of measurement: By a questionnaire of urinary retention: a) the patient's inability to pass urine after surgery, despite feeling a need to urinating for half an hour and leaving every amount of urine after catheterization. B) inability to pass urine for 12 hours after surgery, without feeling a need to urinating and leaving at least 600 cc of urine after catheterization.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath